Browsing by Author Mahaffey, Kenneth W

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)Citation
2017Canagliflozin and cardiovascular and renal events in type 2 diabetesFulcher, Greg; Neal, Bruce; Perkovic, Vlado; de Zeeuw, Dick; Desai, Mehul; Erondu, N; Law, Gordon; Mahaffey, Kenneth W; Matthews, David; Shaw, Wayne; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthCanagliflozin and cardiovascular and renal events in type 2 diabetes, New England Journal of Medicine, vol.377, 7, 2017,pp 644-657
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2015Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled TrialFulcher, Greg; Neal, Bruce; Perkovic, Vlado; Capuano, George; de Zeeuw, Dick; Desai, Mehul; Mahaffey, Kenneth W; Matthews, David. R.; Meininger, G; Rosenstock, Julio; Shaw, Wayne; Vercruysse, Frank; Weiss, Robert; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthEfficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial, Diabetes Therapy, vol.6, 3, 2015,pp 289-302
2016Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetesFulcher, Greg; Neal, Bruce; Perkovic, Vlado; Capuano, George; de Zeeuw, Dick; Desai, Mehul; Mahaffey, Kenneth W; Mathieu, Chantal; Matthews, David. R.; Meininger, G; Shaw, Wayne; Vercruysse, Frank; Woo, Vincent; Wysham, C; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthEfficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes, Diabetes, Obesity and Metabolism, vol.18, 1, 2016,pp 82-91
2015Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 DiabetesFulcher, Greg; Neal, Bruce; Perkovic, Vlado; Alba, Maria; Capuano, George; de Zeeuw, Dick; Desai, Mehul; Jiang, Joel; Mahaffey, Kenneth W; Matthews, David; Meininger, G; Shaw, Wayne; Vercruysse, Frank; Ways, Kirk; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthEfficacy and Safety of Canagliflozin, an Inhibitor of Sodium Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes, Diabetes Care, vol.38, 3, 2015,pp 403-411
2017Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trialFulcher, Greg; Neal, Bruce; Perkovic, Vlado; de Zeeuw, Dick; Deng, Hsiaowei; Desai, Mehul; Erondu, N; Mahaffey, Kenneth W; Matthews, David; Meininger, Gary; Shaw, Wayne; Vercruysse, Frank; Yee, Jacqueline; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthRationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial, Diabetes, Obesity and Metabolism, vol.19, 3, 2017,pp 387-393
2004Risk Factors For Intracranial Hemorrhage And Nonhemorrhagic Stroke After Fibrinolytic Therapy (From The Gusto-I Trial).Simes, Robert John; Califf, Robert M; Gore, Joel M.; Granger, Christopher; Kandzari, David E; Lee, Kerry L; Longstreth, William T; Mahaffey, Kenneth W; Simoons, Maarten L.; Stebbins, Amanda; Topol, Eric J; Weaver, W Douglas; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials CentreRisk Factors For Intracranial Hemorrhage And Nonhemorrhagic Stroke After Fibrinolytic Therapy (From The Gusto-I Trial)., The American Journal of Cardiology, vol.93,(4),2004,pp 458-461